Loading interface...

Valus-P 40 mg Injection

Manufactured byGLENMARK PHARMACEUTICALS LTD
ContainsParecoxib
Description
Valus-P 40 mg Injection is a selective COX-2 inhibitor used for short-term treatment of post-operative pain in adults. This medicine is not recommended for use in patients below 18 years of age.

Side effects

Major & minor side effects for Valus-P 40 mg Injection

  • Abdominal pain
  • Vomiting
  • Constipation
  • Indigestion
  • Flatulence
  • Dizziness
  • Decreased potassium levels
  • Sore throat
  • Anorexia
  • Decreased heartbeat

Uses of Valus-P 40 mg Injection

What is it prescribed for?

  • Post operative pain
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to parecoxib, valdecoxib, any other non-steroidal anti-inflammatory (NSAID) drugs, or any other inactive ingredients present along with this medicine.

Severe Hepatic impairment

This medicine is not recommended for use in patients with a known history of severe hepatic impairment due to the increased risk of worsening of the patient's condition.

Coronary Artery Bypass Surgery (CABG)

This medicine is not recommended for use before, during, or after a coronary artery bypass graft surgery due to the increased risk of severe adverse reactions.

Congestive Heart Failure

This medicine is not recommended for use in patients with a known history of severe congestive heart failure due to the increased risk of worsening of the patient's condition.

Gastro-intestinal bleeding

This medicine is not recommended for use in patients with a known history of gastrointestinal bleeding due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
General warnings

Cardiovascular diseases

This medicine should be used with caution in patients with a known history of cardiovascular diseases due to the increased risk of worsening of the patient's condition. Close monitoring of vital signs and heart function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Renal impairment

This medicine should be used with caution in patients with a known history of kidney diseases due to the increased risk of worsening of the patient's condition. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Gastro-Intestinal Bleeding

This medicine may cause severe bleeding when taken for a long time. This risk is especially high in the elderly population with a history of gastrointestinal diseases. Report any symptoms of blood in stools and vomiting to the doctor immediately. Replacement with a suitable alternative may be required in some cases based on the clinical condition.

Driving or Operating machines

This medicine may cause symptoms such as dizziness in some patients. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating heavy machinery if you experience dizziness during treatment with this medicine.

Use in pediatrics

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Missed Dose

Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, on an as-needed basis, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered by a qualified healthcare professional in the hospital or clinical setting, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Antihypertensives

Tacrolimus

Cyclosporine

Disease interactions

Hepatic impairment

This medicine should be used with caution in patients with a known history of liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is administered by a qualified healthcare professional in the clinical or hospital setting. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines as well as your medical conditions before receiving this medicine. Report any undesired side effects to the doctor immediately.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
It works by inhibiting the formation of certain chemical substances in the body that are responsible for causing pain and swelling.
Legal Status

Approved

Unknown

Unknown

Approved

Classification

Category

Non-steroidal anti-inflammatory agents

Schedule

Schedule H

Parecoxib - DrugBank [Internet]. Drugbank.ca. 2018 [cited 22 March 2018]. Available from:

https://www.drugbank.ca/drugs/DB08439

[Internet]. 2018 [cited 22 March 2018]. Available from:

https://www2.medicines.org.uk/emc/medicine/8771#

[Internet]. 2018 [cited 22 March 2018]. Available from:

https://www2.medicines.org.uk/emc/PIL.14520.latest.pdf

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2018 [cited 22 March 2018]. Available from:

http://www.tga.gov.au/prescribing-medicines-pregnancy-database

[Internet]. Pfizer.com.au. 2018 [cited 22 March 2018]. Available from:

http://www.pfizer.com.au/sites/g/files/g10005016/f/201311/PI_Dynastat_306.pdf

[Internet]. Medsafe.govt.nz. 2018 [cited 22 March 2018]. Available from:

http://www.medsafe.govt.nz/Consumers/CMI/d/dynastat.pdf

[Internet]. E-lactancia.org. 2018 [cited 22 March 2018]. Available from:

http://www.e-lactancia.org/media/papers/Parecoxib-DS2012.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 28 Mar 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.